GHK-Cu Dosage Guide: Protocols, Timing & How Much to Take (2026)

Apply GHK-Cu only to healing or healed lesions. Not active inflamed pustules. The copper ion's antimicrobial properties may reduce surface bacteria, but applying peptides to open lesions increases the risk of contact sensitisation and can delay wound closure. Wait until the lesion has crusted over or fully re-epithelialised (typically 3–5 days post-rupture) before introducing GHK-Cu to prevent PIH formation. The peptide works best as a preventive measure during the inflammatory resolution phase, not during active infection.

Yes. The mechanisms are complementary, not redundant. Minoxidil increases blood flow and nutrient delivery to follicles; GHK-Cu stimulates dermal papilla cells to produce the growth factors that initiate anagen. Combining both addresses two bottlenecks simultaneously. Apply minoxidil first (allow 10 minutes for absorption), then apply topical GHK-Cu or perform subcutaneous injection. Do not mix them in the same solution unless formulated by a compounding pharmacy.

Complex tears with multiple planes of cleavage or degenerative horizontal tears in older tissue present structural damage beyond isolated collagen fiber disruption. The extracellular matrix is fragmented, fibrochondrocyte density is reduced, and inflammatory signaling is chronic rather than acute. GHK-Cu can modulate enzymatic pathways in surviving cells, but it can't regenerate tissue where cellular viability has been lost entirely. In these cases, peptide protocols are adjunctive. They may improve the quality of remaining tissue or slow further degradation, but they won't reverse structural failure that's already occurred.

That's a formulation red flag. GHK-Cu oxidizes at room temperature unless stabilized with antioxidants (like sodium metabisulfite or ascorbic acid) or packaged in vacuum-sealed, light-blocking containers. If the product is transparent, stored on a shelf, and doesn't specify refrigeration after opening, assume 30–50% degradation within the first month. Oxidized copper peptides turn slightly greenish and lose their characteristic faint metallic odor. But those changes aren't always visible until potency is already compromised.

No pharmacokinetic interactions have been documented between topical GHK-Cu and minoxidil or oral finasteride. The mechanisms are complementary: finasteride reduces DHT-driven follicular miniaturization, minoxidil extends anagen phase via potassium channel opening, and GHK-Cu reduces perifollicular inflammation while promoting dermal papilla health. Combination protocols in unpublished observational studies suggest additive benefits, particularly in cases where inflammation is a significant component of AGA progression.